Understanding the genetic and metabolic needs of aggressive breast cancer
Defining genetic and metabolic requirements of aggressive breast cancer
This study is looking at how certain genes and proteins affect aggressive breast cancer, with the goal of finding new treatment options that could help prevent the cancer from getting worse, making it more tailored to what patients need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Cincinnati NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-10829884 on NIH RePORTER |
What this research studies
This research investigates the underlying genetic and metabolic factors that contribute to aggressive forms of breast cancer, particularly focusing on how certain proteins and genes influence cancer growth and recurrence. By studying these factors, the research aims to identify potential targets for new treatments that could prevent the progression of the disease. The approach includes analyzing the behavior of breast cancer cells in laboratory settings to understand their response to various treatments. This could lead to more personalized and effective treatment strategies for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with aggressive breast cancer, particularly those experiencing recurrence or metastasis.
Not a fit: Patients with non-aggressive forms of breast cancer or those who are not currently undergoing treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and prevention strategies for patients with aggressive breast cancer.
How similar studies have performed: Other research has shown promise in targeting specific genetic and metabolic pathways in cancer treatment, suggesting that this approach could yield significant advancements.
Where this research is happening
Cincinnati, United States
- University of Cincinnati — Cincinnati, United States (Active)
Researchers
- Principal investigator: Waltz, Susan E — University of Cincinnati
- Study coordinator: Waltz, Susan E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.